NYMOX PHARMACEUTICAL CORP
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NYMXF and buy or sell other stocks, ETFs, and their options commission-free!About NYMXF
Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer.
CEOPaul Averback
CEOPaul Averback
Employees—
Employees—
HeadquartersNassau, New Providence
HeadquartersNassau, New Providence
Founded1995
Founded1995
Employees—
Employees—
NYMXF Key Statistics
Market cap5.11M
Market cap5.11M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume57.97K
Average volume57.97K
High today$0.052
High today$0.052
Low today$0.052
Low today$0.052
Open price$0.052
Open price$0.052
Volume19.50K
Volume19.50K
52 Week high$0.1497
52 Week high$0.1497
52 Week low$0.0322
52 Week low$0.0322
Stock Snapshot
The current NYMOX PHARMACEUTICAL CORP(NYMXF) stock price is $0.05, with a market capitalization of 5.11M. The stock trades at a price-to-earnings (P/E) ratio of -0.54.
On 2025-12-16, NYMOX PHARMACEUTICAL CORP(NYMXF) stock moved within a range of $0.05 to $0.05. With shares now at $0.05, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for NYMOX PHARMACEUTICAL CORP(NYMXF) stock has reached 19.5K, versus its average volume of 57.97K.
The stock's 52-week range extends from a low of $0.03 to a high of $0.15.
The stock's 52-week range extends from a low of $0.03 to a high of $0.15.
People also own
Based on the portfolios of people who own NYMXF. This list is generated using Robinhood data, and it’s not a recommendation.